ArticleDEN open2027
A Novel Biliary Plastic Stent With a Centrally Located Flap: Initial Clinical Experience in Three Cases.
Article in DEN open, 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endoscopic biliary plastic stent (PS) insertion is standard for maintaining bile flow, but migration and dislodgement persist as important challenges. We developed the cross range flap stent (CRF stent), a 7 Fr, 7 cm straight-type PS. Unlike conventional stents with flaps at both ends, the CRF stent features flaps and flap holes at the intestinal end and the center to improve stability and to prevent migration. This report describes three consecutive early cases for which the CRF stent was used for distal malignant biliary stricture caused by pancreatic cancer, acute cholangitis caused by common bile duct stones, and prevention of cholangitis after endoscopic papillectomy. In all cases, the CRF stent was placed easily using its integrated delivery system. No migration or occlusion was observed during the observation periods. The unique centrally located flap appears to be particularly effective for short obstructions and for various clinical conditions. Further largescale comparative studies must be conducted, but the CRF stent has shown potential to minimize stentrelated adverse events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.